History to the Discovery of Ghrelin

Methods in Enzymology

Volumn 514, Issue , 2012, Pages 3-32

  Bowers, Cyril Y ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Ghrelin; GHRP + GHRH Synergistic Release of GH; GHRP Hypothalamic Pituitary Action; GHRPs; GHS 1a Receptor; Increased Food Intake and Body Weight

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING HEXAPEPTIDE; GROWTH HORMONE-RELEASING PEPTIDE-2; OLIGOPEPTIDE; PRALMORELIN;

ANIMAL; ARTICLE; BIOASSAY; DRUG EFFECT; DRUG POTENTIATION; EATING; HISTORY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METHODOLOGY; PHYSIOLOGY; SECRETION (PROCESS); SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BIOLOGICAL ASSAY; DRUG SYNERGISM; EATING; GHRELIN; GROWTH HORMONE-RELEASING HORMONE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INFUSIONS, SUBCUTANEOUS; OLIGOPEPTIDES; RECEPTORS, GHRELIN;

MLCS; MLOWN;

EID: 84873466439     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381272-8.00001-5     Document Type: Chapter

References (77)

1. Adams, E.F., Lei, T., Buchfelder, M., Bowers, C.Y., Fahlbusch, R., Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3’,5’-monophosphate production by human pituitary somatotropinomas expressing gsp ncogenes: evidence for cross-talk between transduction pathways. Mol. Endocrinol. 10 (1996), 432–438.
2. 3 cells. J. Clin. Endocrinol. Metab. 83 (1998), 638–642.
3. 2), GH releasing hormone, and thyrotropin releasing hormone in acromegaly. J. Clin. Endocrinol. Metab. 77 (1993), 842–845.
4. Badger, T.M., Millard, W.J., McCormick, G.F., Bowers, C.Y., Martin, J.B., The effects of growth hormone (GH) releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 115 (1984), 1432–1438.
5. Bitar, K.G., Bowers, C.Y., Coy, D.H., Effects of substance P/Bombesin antagonists on the release of growth hormone by GHRP and GHRH. Biochem. Biophys. Res. Commun. 180 (1991), 156–161.
6. Boler, J., Enzmann, F., Folkers, K., Bowers, C.Y., Schally, A.V., The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem. Biophys. Res. Commun. 37 (1969), 705–710.
7. Bowers, C.Y., Studies on the role of cyclic AMP in the release of anterior pituitary hormones. Robinson, G.A., Nahas, G.G., Triner, L., (eds.) Annals of the New York Academy of Sciences, vol. 185, 1971, New York Academy of Sciences, USA, 263–290.
8. Bowers, C.Y., A new dimension on the induced release of growth hormone in obese subjects. J. Clin. Endocrinol. Metab. 76 (1993), 817–818.
9. Bowers, C.Y., On a peptidomimetic growth hormone releasing peptide (GHRP). J. Clin. Endocrinol. Metab. 79 (1994), 940–942.
10. Bowers, C.Y., Xenobiotic growth hormone secretagogues: growth hormone releasing peptides. Bercu, B.B., Walker, R.F., (eds.) Growth Hormone Secretagogues, 1996, Springer-Verlag, New York, 9–28.
11. Bowers, C.Y., Growth hormone releasing peptide (GHRP). Cell. Mol. Life Sci. 54 (1998), 1316–1329.
12. Bowers, C.Y., Synergistic release of growth hormone by GHRP and GHRH: scope and implication. Bercu, B.B., Walker, R.F., (eds.) Growth Hormone Secretagogues in Clinical Practice, 1998, Marcel Dekker, New York/Basel/Hong Kong, 1–25.
13. Bowers, C.Y., Growth hormone releasing peptides (GHRPs). Kostyo, J., Goodman, H.M., (eds.) Handbook of Physiology, 1999, Oxford University Press, New York/Oxford, 267–297.
14. Bowers, C.Y., Unnatural toward the natural. Ghigo, E., Boghen, M., Casanueva, F.F., Dieguez, C., (eds.) Growth Hormone Secretagogues, 1999, Elsevier, New York, 5–18.
15. Bowers, C.Y., GHRP-GH secretagogues. Bengtsson, B.-A., (eds.) Growth Hormone, 1999, Kluwer Academic Publishers, Boston/Dordrecht/London, 335–351.
16. Bowers, C.Y., Unnatural growth hormone releasing peptide begets natural ghrelin. J. Clin. Endocrinol. Metab. 86 (2001), 1464–1469.
17. Bowers, C.Y., New insights into the control of growth hormone secretion. Kleinberg, D.L., Clemmons, D.R., (eds.) Central and Peripheral Metabolisms in Pituitary Disease, 2002, BioScientifica Ltd., Bristol, 163–176.
18. 2 and in combination in older obese men and women with decreased growth hormone secretion. Endocrine 14:1 (2001), 79–86.
19. Bowers, C.Y., Schally, A.V., Assay of thyrotropin releasing hormone. Meites, J., (eds.), Proceedings of NIH Conference on Hypothalamic Hypophysiotropic Hormones, 1969, The Williams and Wilkins Company, Baltimore, Maryland, 74–80.
20. 2. Endocrinology 86 (1970), 1143–1153.
21. Bowers, C.Y., Schally, A.V., Weil, A., Reynolds, G.A., Folkers, K., Chemical and biological identity of thyrotropin releasing hormone (TRH) of bovine and human origin. Fellinger, K., Hofer, R., (eds.) Further Advances in Thyroid Research, vol. 2, 1971, Verlag der Wiener Medizinischen Akademie, Vienna, Austria, 1029–1049.
22. Bowers, C.Y., Friesen, H., Folkers, K., Further evidence that TRH is also a physiological regulator of PRL secretion in man. Biochem. Biophys. Res. Commun. 51 (1973), 512–521.
23. 2 (Decapeptide), its analogs and other small peptides. Gual, C., Rosemberg, E., (eds.) Hypothalamic Hypophysiotropic Hormones, 1973, Excerpta Medica Foundation, Amsterdam, 68–88.
24. Bowers, C.Y., Friesen, H.G., Malacara, J.M., Folkers, K., Clinical uses of hypothalamic releasing hormones. McMahon, F.G., (eds.) Endocrine-Metabolic Drugs, Vol. VI, 1975, Futura Publishing Company, Inc, Mount Kisco, New York, 115–152.
25. Bowers, C.Y., Chang, J., Momany, F., Folkers, K., Effect of the enkephalins and enkephalin analogs on release of pituitary hormones in vitro. MacIntyre, I., Szelke, M., (eds.) Proceedings of 6th International Conference on Endocrinology, Molecular Endocrinology, 1977, Elsevier/North Holland, Amsterdam, 287–292.
26. Bowers, C.Y., Momany, F., Chang, D., Hong, A., Chang, K., Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology 106:3 (1980), 663–667.
27. Bowers, C.Y., Reynolds, G.A., Chang, D., Hong, A., Chang, K., Momany, F., A study on the regulation of GH release from the pituitary of rats in vitro. Endocrinology 108:3 (1981), 1071–1079.
28. Bowers, C.Y., Momany, F., Reynolods, G.A., In vitro and in vivo activity of a small synthetic peptide with potent GH releasing activity. 1982, (Abstract) The Endocrine Society, San Francisco, CA P. 205.
29. Bowers, C.Y., Reynolds, G.A., Hong, A., Momany, F., Studies on pituitary cyclic AMP and GH levels and the release of GH in vitro. Bhatnager, A.S., (eds.) The Anterior Pituitary Gland, 1983, Raven Press, New York, 165–176.
30. Bowers, C.Y., Reynolds, G.A., Momany, F., New advances on the regulation of growth hormone (GH) secretion. Int. J. Neurol. 18 (1984), 188–205.
31. Bowers, C.Y., Momany, F., Reynolds, G.A., Hong, A., On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114 (1984), 1537–1545.
32. Bowers, C.Y., Reynolds, G.A., Durham, D., Barrera, C.M., Pezzoli, S.S., Thorner, M.O., Growth hormone releasing peptide stimulates GH release in normal men and acts synergistically with GH releasing hormone. J. Clin. Endocrinol. Metab. 70 (1990), 975–982.
33. Bowers, C.Y., Sartor, A.O., Reynolds, G.A., Badger, T.M., On the actions of the growth hormone releasing hexapeptide, GHRP. Endocrinology 128 (1991), 2027–2035.
34. Bowers, C.Y., Alster, D.K., Frentz, J.M., The growth hormone releasing activity of a synthetic hexapeptide in normal men and short statured children after oral administration. J. Clin. Endocrinol. Metab. 74 (1992), 292–298.
35. Bowers, C.Y., Veeraragavan, K., Sethumadhavan, K., Atypical growth hormone releasing peptides. Bercu, B.B., Walker, R.F., (eds.) Growth Hormone II Basic and Clinical Aspects, 1994, Springer-Verlag, New York, 203–222.
36. Bowers, C.Y., Granda, R., Mohan, S., Kuipers, J., Baylink, D., Veldhuis, J.D., Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3) and IGFBP-5 concentrations during 30 day continuous subcutaneous infusion of GH releasing peptide-2 in older men and women. J. Clin. Endocrinol. Metab. 89 (2004), 2290–2300.
37. Bowers, C.Y., Octanoyl ghrelin is hypothalamic rooted. Endocrinology 146 (2005), 2508–2509.
38. Bowers, C.Y., Laferrere, B., Hurley, D.L., Veldhuis, J.D., The role of growth hormone secretagogues and ghrelin in feeding and body composition. Donohoue, P.A., (eds.) Energy Metabolism and Obesity, 2008, Humana Press, Totowa, New Jersey, 125–154.
39. Bowers, C.Y., Reynolds, G.A., Veldhuis, J.D., Ghrelin: a history of its discovery. Smith, R.G., Thorner, M.O., (eds.) Ghrelin in Health and Disease, 2012, Springer Science + Business Media, Inc, New York, 1–35.
40. Brazeau, P.W., Vale, W., Burgus, R., Ling, N., Butcher, M., Riviere, J., Guillemin, R., Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179 (1973), 77–79.
41. Burgus, R., Dunn, T.F., Ward, D.N., Vale, W., Amoss, M., Guillemin, R., Derives poltyeptidiques de synthese doues d'activite hypophysiotrope TRF. C.R. Acad. Sci. Paris 268 (1969), 2116–2118.
42. Codd, E.E., Shu, A., Walker, R.F., Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary sites. Neuropharmacology 28 (1989), 1139–1144.
43. Folkers, K., Enzmann, F., Boler, J., Bowers, C.Y., Schally, A.V., Discovery of modification of the synthetic tripeptide sequence of the thyrotropin releasing hormone having activity. Biochem. Biophys. Res. Commun. 37 (1969), 123–126.
44. Guillemin, R., Growth hormone releasing factor: a brief history of its time. Bercu, B.B., Walker, R., (eds.) Growth Hormone Secretagogues, 1996, Springer-Verlag, New York, 3–8.
45. Guillemin, R., Brazeau, P., Bohlen, P., Esch, F., Ling, N., Wehrenberg, W.B., Growth hormone releasing factor from a human pancreatic tumor that caused acromegaly. Science 218 (1982), 585–587.
46. Holst, B., Cygankiewicz, A., Jensen, T.H., Ankersen, M., Schwartz, T.W., High constitutively signaling of the ghrelin receptor-identification of a potent inverse agonist. Mol. Endocrinol. 17 (2003), 2201–2210.
47. Howard, A.D., Feighner, S.D., Cully, D.F., Arena, J.P., Liberator, P.A., Rosenblum, C.I., Hamelin, M., Hreniuk, D.L., Palyha, O.C., Anderson, J., Paress, P.S., Diaz, C., Chou, M., Liu, K.K., McKee, K.K., Pong, S.S., Chaung, L.Y., Elbrecht, A., Dashkevicz, M., Heavens, R., Rigby, M., Sirinathsinghji, D.J.S., Dean, D.D., Melillo, D.G., Patchett, A.A., Nargund, R., Griffin, P.R., DeMartino, J.A., Gupta, S.K., Schaeffer, J.M., Smith, R.G., Van der Ploeg, L.H.T., A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273 (1996), 974–977.
48. Jaffe, C.A., Ho, J., Demott-Frieberg, R.D., Bowers, C.Y., Barkan, A.L., Effects of a prolonged growth hormone (GH) releasing peptide infusion on pulsatile GH secretion in normal men. J. Clin. Endocrinol. Metab. 77 (1993), 1641–1647.
49. Klinger, B., Silbergeld, A., Deghenghi, R., Frenkel, J., Laron, Z., Desensitization from long term intranasal treatment with hexarelin does not interfere with the biological effects of this growth hormone releasing peptide in short children. Eur. J. Endocrinol. 134 (1996), 716–719.
50. Kojima, M., Hosada, H., Date, Y., Nakazato, M., Matsuo, M., Kangawa, K., Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature 402 (1999), 656–660.
51. Locke, W., Kirgis, H.D., Bowers, C.Y., Abdoh, A.A., Effect of intracerebroventricular injection of growth hormone releasing peptide on feeding behavior and plasma growth hormone levels of rats. Life Sci. 56 (1995), 1347–1352.
52. McCormick, G.F., Millard, W.J., Badger, T.M., Bowers, C.Y., Martin, J.B., Dose-response characteristics of various peptides with growth hormone releasing activity in the unanesthetized male rat. Endocrinology 117 (1985), 97–105.
53. Mericq, V., Cassorla, F., Garcia, H., Avila, A., Bowers, C.Y., Merriam, G., Growth hormone responses to growth hormone releasing peptide (GHRP) in growth hormone deficient children (GHD). J. Clin. Endocrinol. Metab. 80 (1995), 1681–1684.
54. Mericq, V., Cassorla, F., Salazar, T., Avila, A., Inguez, G., Bowers, C.Y., Merriam, G.R., Effects of eight months treatment with graded doses of a growth hormone releasing peptide in GH-deficient children. J. Clin. Endocrinol. Metab. 83 (1998), 2355–2360.
55. Momany, F.A., Bowers, C.Y., Computer assisted modeling of xenobiotic growth hormone secretagogues. Bercu, B.B., Walker, R.F., (eds.) Growth Hormone Secretagogues, 1996, Springer, New York, 73–83.
56. Momany, F., Bowers, C.Y., Reynolds, G.A., Chang, D., Hong, A., Newlander, K., Design, synthesis and biological activity of peptides which release growth hormone in vitro. Endocrinology 108:1 (1981), 31–39.
57. Momany, F., Bowers, C.Y., Reynolds, G.A., Hong, A., Newlander, K., Conformational energy studies and in vivo activity data on active GH releasing peptides. Endocrinology 114 (1984), 1531–1536.
58. Okada, K., Ishii, S., Minami, S., Sugihara, H., Shibasaki, T., Wakabayashi, I., Intracerebroventricular administration of the growth hormone releasing peptide KP-102 increases food intake in free-feeding rats. Endocrinology 137:11 (1996), 5155–5158.
59. Pandya, C.A., Demott-Friberg, R., Bowers, C.Y., Barkan, A.L., Jaffe, C.A., Growth hormone (GH) releasing peptide-6 requires endogenous hypothalamic GH releasing hormone for maximal GH stimulation. J. Clin. Endocrinol. Metab. 83 (1998), 1186–1189.
60. Pihoker, C., Middleton, R., Reynolds, G.A., Bowers, C.Y., Badger, T.M., Diagnostic studies with intravenous and intranasal growth hormone releasing peptide-2 in children of short stature. J. Clin. Endocrinol. Metab. 80 (1995), 2987–2992.
61. Pihoker, C., Badger, T.M., Reynolds, G.A., Bowers, C.Y., Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J. Endocrinol. 155 (1997), 79–86.
62. Pihoker, C., Kearns, G.L., French, D., Bowers, C.Y., Pharmacokinetics and pharmacodynamics of growth hormone releasing peptide-2: a phase I study in children. J. Clin. Endocrinol. Metab. 83 (1998), 1168–1172.
63. Rivier, K.J., Spiess, M., Thorner, M., Vale, W., Characterization of a growth hormone releasing factor from a human pancreatic islet tumor. Nature 300 (1982), 276–278.
64. 2 and hpGRF in rat pituitary primary cell monolayer culture. Endocrinology 116 (1985), 952–957.
65. 2 (GHRP-6) in the rat. Endocrinology 117 (1985), 1441–1447.
66. Sato, T., Fukue, Y., Teranishi, H., Yoshida, Y., Kojima, M., Molecular forms of hypothalamic ghrelin and its regulation by fasting and 2-deoxy-D-glucose administration. Endocrinology 146 (2005), 2510–2516.
67. Schally, A.V., Bowers, C.Y., Purification of luteinizing hormone releasing factor from bovine hypothalami. Endocrinology 75 (1964), 608–614.
68. Schally, A.V., Bowers, C.Y., The nature of thyrotropin-releasing hormone (TRH). Kenny, A.D., Anderson, R.R., (eds.), Proceedings of Sixth Midwest Conference on the Thyroid and Endocrinology, 1970, University of Missouri, Columbia, 25–63.
69. Schally, A.V., Bowers, C.Y., Redding, T.W., Barrett, J.F., Isolation of thyrotropin releasing factor (TRF) from porcine hypothalamus. Biochem. Biophys. Res. Commun. 25 (1966), 165–169.
70. Schally, A.V., Redding, T.W., Bowers, C.Y., Barrett, J.F., Isolation and properties of porcine thyrotropin releasing hormone. J. Biol. Chem. 244 (1969), 4077–4088.
71. Sethumadhavan, K., Veeraragavan, K., Bowers, C.Y., Demonstration and characterization of the specific binding of growth hormone releasing peptide (GHRP) to rat anterior pituitary and hypothalamic membranes. Biochem. Biophys. Res. Commun. 178 (1991), 31–37.
72. Smith, R.G., Pong, S.S., Hickey, G., Jacks, T., Cheng, K., Leonard, R., Cohen, C.J., Arena, J.P., Chang, C.H., Drisko, J., Wyvratt, M., Fisher, M., Nargund, R., Patchett, A., Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Conn, P.M., (eds.) Recent Progress in Hormone Research, 1996, The Endocrine Society, Bethesda, Maryland, 261–286.
73. Tannenbaum, G.S., Bowers, C.Y., Interactions of growth hormone secretagogues and growth hormone releasing hormone/somatostatin. Endocrine 14 (2001), 21–27.
74. Tannenbaum, G.S., Epelbaum, J., Bowers, C.Y., Interrelationship between the most novel peptide ghrelin and somatostatin/growth hormone releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144 (2003), 967–974.
75. Van den Berghe, G., Wouters, P., Weekers, F., Mohan, S., Baxter, R.C., Veldhuis, J.D., Bowers, C.Y., Bouillon, R., Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone releasing peptide and thyrotropin releasing peptide in patients with protracted critical illness. J. Clin. Endocrinol. Metab. 84 (1999), 1311–1323.
76. Van der Ploeg, L.H.T., Howard, A.D., Smith, R.G., Feighner, S.D., Molecular cloning and characterization of human, swine, and rat growth hormone secretagogue receptors. Bercu, B.B., Walker, R.F., (eds.) Growth Hormone Secretagogues, 1998, Markel Dekker, Inc, New York, 57–76.
77. Veeraragavan, K., Sethumadhavan, K., Bowers, C.Y., Growth hormone releasing peptide (GHRP) binding to porcine anterior pituitary and hypothalamic membranes. Life Sci. 50 (1992), 1149–1155.